Coloplast A/S (LON:0QBO)

Market Cap	18.68B
Revenue (ttm)	3.04B
Net Income (ttm)	541.57M
Shares Out	n/a
EPS (ttm)	2.41
PE Ratio	34.50
Forward PE	n/a
Dividend	2.47 (0.35%)
Ex-Dividend Date	Dec 6, 2024

Volume	12,680
Average Volume	32,686
Open	699.60
Previous Close	707.53
Day's Range	698.40 - 704.40
52-Week Range	84.20 - 108.53
Beta	0.60
RSI	53.34
Earnings Date	May 6, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,639
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QBO

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK